Regal Rexnord Corporation (RRX) is down 7.6% today. Here is some analysis on what might have caused this price movement.
Analysis: A clear, single-stock catalyst for today’s decline is not obvious from company disclosures, so the move looks consistent with a pullback after a strong run and heightened sensitivity to execution risk. This could be because investors are re-pricing near-term uncertainty tied to the ongoing CEO succession timeline and restructuring actions, ahead of the next earnings update.
Details:
Sources:
Regal Rexnord Investor Relations, PR Newswire, Seehafer News
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$RRX Insider Trading Activity
$RRX insiders have traded $RRX stock on the open market 21 times in the past 6 months. Of those trades, 0 have been purchases and 21 have been sales.
Here’s a breakdown of recent trading of $RRX stock by insiders over the last 6 months:
- LOUIS V. PINKHAM (Chief Executive Officer) has made 0 purchases and 12 sales selling 72,663 shares for an estimated $13,169,321.
- ROBERT REHARD (EVP and CFO*) has made 0 purchases and 3 sales selling 9,961 shares for an estimated $2,173,089.
- JERRALD R MORTON (EVP and Pres. IPS*) has made 0 purchases and 2 sales selling 7,978 shares for an estimated $1,721,445.
- CURTIS W STOELTING has made 0 purchases and 2 sales selling 9,000 shares for an estimated $1,710,000.
- CHERYL LEWIS (EVP and Chief HR Officer*) sold 2,262 shares for an estimated $487,981
- ALEXANDER P SCARPELLI (SVP, Corp. Controller and CAO*) sold 290 shares for an estimated $64,887
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RRX Hedge Fund Activity
We have seen 220 institutional investors add shares of $RRX stock to their portfolio, and 243 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 3,930,634 shares (-82.8%) from their portfolio in Q4 2025, for an estimated $551,546,562
- VICTORY CAPITAL MANAGEMENT INC added 1,690,264 shares (+42.6%) to their portfolio in Q4 2025, for an estimated $237,177,844
- CAPITAL WORLD INVESTORS removed 1,225,381 shares (-31.3%) from their portfolio in Q4 2025, for an estimated $171,945,461
- NORGES BANK removed 902,614 shares (-51.1%) from their portfolio in Q4 2025, for an estimated $126,654,796
- FMR LLC removed 846,292 shares (-17.6%) from their portfolio in Q4 2025, for an estimated $118,751,693
- MACQUARIE GROUP LTD removed 522,720 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $73,348,070
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 502,677 shares (-18.8%) from their portfolio in Q4 2025, for an estimated $70,535,636
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$RRX Analyst Ratings
Wall Street analysts have issued reports on $RRX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 10/31/2025
To track analyst ratings and price targets for $RRX, check out Quiver Quantitative's $RRX forecast page.
$RRX Price Targets
Multiple analysts have issued price targets for $RRX recently. We have seen 7 analysts offer price targets for $RRX in the last 6 months, with a median target of $230.0.
Here are some recent targets:
- Kyle Menges from Citigroup set a target price of $240.0 on 04/13/2026
- Julian Mitchell from Barclays set a target price of $245.0 on 03/23/2026
- Jeffrey Hammond from Keybanc set a target price of $255.0 on 02/10/2026
- Joe Ritchie from Goldman Sachs set a target price of $230.0 on 02/09/2026
- Christopher Glynn from Oppenheimer set a target price of $225.0 on 02/06/2026
- Tomohiko Sano from JP Morgan set a target price of $230.0 on 02/06/2026
- Saree Boroditsky from Jefferies set a target price of $160.0 on 12/10/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.